mesoView Co., Ltd.
Established 2022

About mesoView

mesoView Co. Ltd., founded in 2022, is an original Taiwanese medical imaging technology company. Our key technology was transferred from the Graduate Institute of Photonics and Optoelectronics at National Taiwan University. Our research team there pioneered the development of the globally leading mesoscale Nonlinear Optical Gigascope (mNLOG) platform technology, which has opened new frontiers in Nonlinear Optical Microscopy (NLOM). Utilizing this key technology, mesoView has developed NLOM imaging systems featuring a fine millimeter-scale field of view, submicron imaging resolution, and faster scanning speeds.

mesoView Team
Lab Equipment

Our mission

Microscopic precision, macroscopic impact

Redefining clinical and medical imaging

mesoView is committed to advancing clinical microscope technologies that improve diagnostic precision and healthcare efficiency worldwide. By partnering with top medical experts and photonics innovators, we’re expanding the role of nonlinear mesoscopes in pathology, neurology, dermatology, and surgery. Our R&D also integrates AI to elevate imaging performance. With continuous innovation, we aim to bring Taiwan’s medical device excellence to the global stage.

3+

Global Patents

100%

Taiwan Original

Core Technology

Our mNLOG platform delivers submicron resolution with a fine millimeter-scale field of view.

High-Speed Scanning

Real-time clinical feedback powered by our proprietary scanning algorithms, drastically reducing diagnostic wait times.

Sub-Micron Resolution

Visualize subcellular structures with crystal clarity, enabling precise identification of pathological markers.

AI Integration

Seamlessly integrated machine learning models assist in automated pattern recognition and decision support.

Our Journey

From university research to global innovation.

Ready to collaborate?

Join us in revolutionizing the future of medical pathology and imaging.